- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04158297
ESWL Versus SOPIL for Treatment of Pancreatic Duct Stones
Extracorporeal Shock Wave Lithotripsy Versus Single Operator Pancreatoscopy and Intraductal Lithotripsy for the Treatment of Pancreatic Duct Stones
Pancreatic duct stones can cause obstruction of the main pancreatic duct leading to abdominal pain, exocrine pancreatic insufficiency, and recurrent acute pancreatitis. By removing pancreatic duct stones, the obstruction can be relieved, and this can improve symptoms. Small stones can be removed with standard endoscopic retrograde cholangiopancreatography (ERCP) and stone removal, but larger stones may require lithotripsy to break up the stone before removal. The two current methods of lithotripsy include extracorporeal shock wave lithotripsy (ESWL) and single operator pancreatoscopy with intracorporeal lithotripsy (SOPIL).
ESWL is based on concentrating shock wave energy to the stone through an external device. SOPIL is a newer technique based on direct visualization of the stone during ERCP and targeting the stone with a shock wave catheter. There are currently no studies directly comparing ESWL to SOPIL for breaking apart stones in the pancreatic duct, so this study is designed to compare the two techniques.
Objective #1: Obtain pilot data to determine the optimal method of clearing large MPDS Objective #2: Obtain pilot data to assess how effective large MPDS clearance is in improving long term patient centered outcomes Objective #3: Obtain pilot data to measure the cost effectiveness of large MPDS clearance
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Suzette Schmidt, RN
- Phone Number: 317-278-0691
- Email: suschmid@iu.edu
Study Contact Backup
- Name: Vanessa Patrick
- Phone Number: 317-278-0692
- Email: vpatrick@iu.edu
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana University Health Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- MPDS located in the head, neck, or neck/body junction of the pancreas
- MPDS > 5 mm in size
- Abdominal CT scan, Endoscopic ultrasound, or prior ERCP demonstrating MPDS
- Abdominal pain related to MPDS
- Previously failed ERCP performed with intent to clear MPDS, OR MPDS determined by treating physicians to not be amenable to clearance by standard ERCP techniques
Exclusion Criteria:
- MPDS predominantly located in the body and tail of pancreas
- Any obstructing MPDS > 5 mm located in the body and tail of pancreas
- Known pancreatic head stricture precluding passage of the pancreatoscope with endoscopic stone extraction based on prior imaging or prior ERCP
- Pancreatic head mass
- Impacted MPDS located at the pancreatic duct orifice
- Prior attempts at ESWL or SOPIL for MPDS
- Walled off pancreatic necrosis
- Active alcohol use, defined as any alcohol use within 2 months
- Surgically altered anatomy (see text)
- Gastric outlet obstruction or obstruction precluding passage of the endoscope
- Standard contraindications to ERCP
- Implanted cardiac pacemakers or defibrillators
- Known calcified aneurysms in the path of the shockwave
- Age < 18 years, pregnancy, incarceration, unwillingness/inability to provide informed consent, or anticipated inability to follow protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: ESWL
Extracorporeal shock wave lithotripsy for the treatment of pancreatic duct stones
|
To compare the efficacy of single operator pancreatoscopy (SOP) with intracorporeal lithotripsy (SOPIL) to extracorporeal shock wave lithotripsy (ESWL) for the treatment of main pancreatic duct stones (MPDS) in patients with chronic pancreatitis.
|
Active Comparator: SOPIL
Single Operator Pancreatoscopy and intraductal lithotripsy for the treatment of pancreatic duct stones
|
To compare the efficacy of single operator pancreatoscopy (SOP) with intracorporeal lithotripsy (SOPIL) to extracorporeal shock wave lithotripsy (ESWL) for the treatment of main pancreatic duct stones (MPDS) in patients with chronic pancreatitis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Technical success of complete or partial clearance (≥80% stone clearance) of large main pancreatic duct stone
Time Frame: Up to 24 weeks
|
This will be described as a proportion of patients with stone clearance.
This is defined by the endoscopist's interpretation of the pancreatogram during the time of ERCP and/or subsequent imaging studies.
Two blinded endoscopists will review the final pancreatogram to confirm clearance of MPDS
|
Up to 24 weeks
|
Mean number of lithotripsy and ERCP procedures needed for clearance of stones or in the attempt to clear stones
Time Frame: Up to 24 weeks
|
Combined lithotripsy and ERCP procedures
|
Up to 24 weeks
|
Procedural related adverse events
Time Frame: Up to 24 weeks
|
This will be described as a proportion of patients who develop post-procedure pancreatitis, bleeding, infection, perforation, organ injury, symptomatic hematoma, or Steinstrasse resulting in acute stone impaction at the papilla
|
Up to 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pain scores
Time Frame: through study completion, an average of 1 year
|
Change in Izbicki pain scores from baseline at 3 months, 6 months, 9 months, and 12 months.
The Izbicki pain scale is a validated pain score for chronic pancreatitis using a visual analog scale, frequency of pain, requirement of pain medication, and pain affecting functional ability.
The score ranges from 0 to 100 with higher scores suggesting more pain.
|
through study completion, an average of 1 year
|
Change in quality of life based on chronic pancreatitis specific instruments: PANQOLI
Time Frame: through study completion, an average of 1 year
|
Change in the pancreatitis quality of life instrument (PANQOLI) scores from baseline at 3 months, 6 months, 9 months, and 12 months.
The PANQOLI score is a validated quality of life score for chronic pancreatitis with specific focus on the domains of physical function, role function, emotional function, and self-worth.
The score ranges from 11 to 103, which higher scores suggesting better quality of life.
|
through study completion, an average of 1 year
|
Change in narcotic pain medication usage
Time Frame: through study completion, an average of 1 year
|
Change in daily morphine milligram equivalent usage from baseline at 3 months, 6 months, 9 months, and 12 months
|
through study completion, an average of 1 year
|
Change in exocrine insufficiency
Time Frame: through study completion, an average of 1 year
|
This will be described as a proportion of patients who experience weight gain, resolution of steatorrhea, or no longer require pancreatic enzyme supplementation after stone clearance at 3 months, 6 months, 9 months, and 12 months
|
through study completion, an average of 1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean cost of care for stone clearance
Time Frame: up to 24 weeks
|
Costs will be estimated by procedural fees including the cost of ESWL, lithotripsy, ERCP, anesthesia, and fluoroscopy.
|
up to 24 weeks
|
Health care utilization
Time Frame: through study completion, an average of 1 year
|
Change in frequency of emergency room visits or hospitalization after treatment
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jeffery J Easler, MD, Indiana University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1909140534
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pancreatitis
-
Changhai HospitalUnknownChronic Pancreatitis | Idiopathic Chronic PancreatitisChina
-
AbbottCompletedExocrine Pancreatic Insufficiency, Chronic PancreatitisJapan
-
Postgraduate Institute of Medical Education and...Completed
-
Dartmouth-Hitchcock Medical CenterCompleted
-
The Cleveland ClinicChiRhoClin, Inc.; The National Pancreas FoundationCompletedChronic PancreatitisUnited States
-
Massachusetts General HospitalTerminatedChronic PancreatitisUnited States
-
Winthrop University HospitalCelgene CorporationTerminatedChronic Pancreatitis
-
Beth Israel Deaconess Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Kangen Pharmaceuticals, IncCompletedChronic PancreatitisUnited States, Russian Federation, Ukraine
Clinical Trials on ESWL vs SOPIL
-
Akdeniz UniversityTÜBİTAKNot yet recruitingExtracorporeal Shock Wave Lithotripsy | Lithotripsy
-
Queen Mary Hospital, Hong KongRecruitingUrinary Calculi | Urinary Stones | Urinary Tract StonesChina
-
First People's Hospital of HangzhouEnrolling by invitation
-
Cairo UniversityCompleted
-
Cairo UniversityBeni-Suef UniversityCompletedUreteric StoneEgypt
-
Cairo UniversityBeni-Suef UniversityUnknown
-
Washington University School of MedicineTerminatedUrolithiasisUnited States
-
Asian Institute of Gastroenterology, IndiaAalborg University HospitalCompletedChronic Pain | Chronic PancreatitisIndia
-
Azienda Ospedaliera Città della Salute e della...Completed